Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The peptides dual mechanism of simultaneously enhancing lipolysis and inhibiting lipogenesis creates optimal metabolic conditions for fat loss while preserving lean tissue
AOD-9604, a synthetic fragment derived from the C-terminal region of human growth hormone, has been subjected to extensive clinical evaluation involving over 900 participants across six randomized controlled trials
Users should expect gradual, sustainable improvements rather than rapid, dramatic transformations
This was confirmed across multiple studies measuring serum IGF-1 at baseline and throughout treatment
The Phase 2 clinical trial showed roughly 2-3 kg more fat loss than placebo over 12 weeks, with no impact on blood sugar, insulin, IGF-1, or any hormonal marker
Some users mentally divide the abdomen into quadrants and rotate clockwise
